Search

Kevin E. Weddington

Examiner (ID: 6966)

Most Active Art Unit
1614
Art Unit(s)
1614, 1205, 1629, 2899
Total Applications
3386
Issued Applications
2180
Pending Applications
434
Abandoned Applications
815

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4534265 [patent_doc_number] => 07872040 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-01-18 [patent_title] => 'Receptor blocker and vasodilator comprising indole derivative as active ingredient' [patent_app_type] => utility [patent_app_number] => 11/663748 [patent_app_country] => US [patent_app_date] => 2005-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5950 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/872/07872040.pdf [firstpage_image] =>[orig_patent_app_number] => 11663748 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/663748
Receptor blocker and vasodilator comprising indole derivative as active ingredient Sep 15, 2005 Issued
Array ( [id] => 121876 [patent_doc_number] => 07709524 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'Use of tellurium compounds for inhibition of interleukin-converting enzyme' [patent_app_type] => utility [patent_app_number] => 11/663032 [patent_app_country] => US [patent_app_date] => 2005-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 15704 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709524.pdf [firstpage_image] =>[orig_patent_app_number] => 11663032 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/663032
Use of tellurium compounds for inhibition of interleukin-converting enzyme Sep 14, 2005 Issued
Array ( [id] => 5793096 [patent_doc_number] => 20060013777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Novel treatment for cough' [patent_app_type] => utility [patent_app_number] => 11/225345 [patent_app_country] => US [patent_app_date] => 2005-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9633 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20060013777.pdf [firstpage_image] =>[orig_patent_app_number] => 11225345 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/225345
Novel treatment for cough Sep 11, 2005 Abandoned
Array ( [id] => 5814992 [patent_doc_number] => 20060084670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/224658 [patent_app_country] => US [patent_app_date] => 2005-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3128 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084670.pdf [firstpage_image] =>[orig_patent_app_number] => 11224658 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/224658
Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer Sep 11, 2005 Abandoned
Array ( [id] => 4548899 [patent_doc_number] => 07960410 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-14 [patent_title] => 'Method for treating insulin resistance, abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids with a cortisol inhibitor' [patent_app_type] => utility [patent_app_number] => 11/223074 [patent_app_country] => US [patent_app_date] => 2005-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1507 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/960/07960410.pdf [firstpage_image] =>[orig_patent_app_number] => 11223074 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/223074
Method for treating insulin resistance, abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids with a cortisol inhibitor Sep 9, 2005 Issued
Array ( [id] => 5794105 [patent_doc_number] => 20060014786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Opthalmic pharmaceutical compositions and methods for treating ocular inflammation' [patent_app_type] => utility [patent_app_number] => 11/221744 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7037 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014786.pdf [firstpage_image] =>[orig_patent_app_number] => 11221744 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/221744
Opthalmic pharmaceutical compositions and methods for treating ocular inflammation Sep 8, 2005 Abandoned
Array ( [id] => 5199729 [patent_doc_number] => 20070299047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-27 [patent_title] => 'Combination of Organic Compounds' [patent_app_type] => utility [patent_app_number] => 11/574994 [patent_app_country] => US [patent_app_date] => 2005-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9600 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20070299047.pdf [firstpage_image] =>[orig_patent_app_number] => 11574994 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/574994
Combination of Organic Compounds Sep 7, 2005 Abandoned
Array ( [id] => 5828852 [patent_doc_number] => 20060063702 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Neuromedin U 2 receptor agonists and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/222927 [patent_app_country] => US [patent_app_date] => 2005-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6886 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063702.pdf [firstpage_image] =>[orig_patent_app_number] => 11222927 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/222927
Neuromedin U 2 receptor agonists and uses thereof Sep 7, 2005 Abandoned
Array ( [id] => 5739123 [patent_doc_number] => 20060009514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-12 [patent_title] => 'Method for treating obesity' [patent_app_type] => utility [patent_app_number] => 11/222135 [patent_app_country] => US [patent_app_date] => 2005-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5417 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20060009514.pdf [firstpage_image] =>[orig_patent_app_number] => 11222135 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/222135
Method for treating obesity Sep 6, 2005 Abandoned
Array ( [id] => 5070385 [patent_doc_number] => 20070191487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Galenic formulations of organic compounds' [patent_app_type] => utility [patent_app_number] => 11/219579 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9536 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191487.pdf [firstpage_image] =>[orig_patent_app_number] => 11219579 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/219579
Galenic formulations of organic compounds Sep 1, 2005 Abandoned
Array ( [id] => 5710091 [patent_doc_number] => 20060051436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Composition for controlling excessive calorie intake-induced disorder, food product for controlling excessive calorie intake-induced disorder, skin preparation for external use for controlling excessive calorie intake-induced disorder, and controlling agent for excessive calorie intake-induced disorder' [patent_app_type] => utility [patent_app_number] => 11/219354 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 15995 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051436.pdf [firstpage_image] =>[orig_patent_app_number] => 11219354 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/219354
Composition for controlling excessive calorie intake-induced disorder, food product for controlling excessive calorie intake-induced disorder, skin preparation for external use for controlling excessive calorie intake-induced disorder, and controlling agent for excessive calorie intake-induced disorder Sep 1, 2005 Abandoned
Array ( [id] => 5711108 [patent_doc_number] => 20060052453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Agent for treating Parkinson\'s disease comprising astrocyte function-improving agent as active ingredient' [patent_app_type] => utility [patent_app_number] => 11/216114 [patent_app_country] => US [patent_app_date] => 2005-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2471 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052453.pdf [firstpage_image] =>[orig_patent_app_number] => 11216114 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/216114
Agent for treating Parkinson's disease comprising astrocyte function-improving agent as active ingredient Aug 31, 2005 Abandoned
Array ( [id] => 5016718 [patent_doc_number] => 20070259927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Remedy for Diabetes' [patent_app_type] => utility [patent_app_number] => 11/660939 [patent_app_country] => US [patent_app_date] => 2005-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17612 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259927.pdf [firstpage_image] =>[orig_patent_app_number] => 11660939 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/660939
Remedy for Diabetes Aug 24, 2005 Abandoned
Array ( [id] => 5777457 [patent_doc_number] => 20060106097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Metabolism-modulating agents and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/205279 [patent_app_country] => US [patent_app_date] => 2005-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 66194 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20060106097.pdf [firstpage_image] =>[orig_patent_app_number] => 11205279 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/205279
Metabolism-modulating agents and uses therefor Aug 15, 2005 Issued
Array ( [id] => 5154935 [patent_doc_number] => 20070037818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Discovery of valuable properties for the primary energy source \"PES 2000 plus Folic Acid\"' [patent_app_type] => utility [patent_app_number] => 11/203465 [patent_app_country] => US [patent_app_date] => 2005-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 170 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20070037818.pdf [firstpage_image] =>[orig_patent_app_number] => 11203465 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/203465
Discovery of valuable properties for the primary energy source "PES 2000 plus Folic Acid" Aug 14, 2005 Pending
Array ( [id] => 5801376 [patent_doc_number] => 20060035864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders' [patent_app_type] => utility [patent_app_number] => 11/202272 [patent_app_country] => US [patent_app_date] => 2005-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7229 [patent_no_of_claims] => 123 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035864.pdf [firstpage_image] =>[orig_patent_app_number] => 11202272 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/202272
Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders Aug 9, 2005 Abandoned
Array ( [id] => 5711109 [patent_doc_number] => 20060052454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Glycine as a diet supplement for the treatment of a wide range of health problems that result from underlying metabolic disorders' [patent_app_type] => utility [patent_app_number] => 11/199327 [patent_app_country] => US [patent_app_date] => 2005-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11094 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052454.pdf [firstpage_image] =>[orig_patent_app_number] => 11199327 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/199327
Glycine as a diet supplement for the treatment of a wide range of health problems that result from underlying metabolic disorders Aug 7, 2005 Abandoned
Array ( [id] => 6978582 [patent_doc_number] => 20050288300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Methods of use fluoroquinolone compounds against maxillary sinus pathogenic bacteria' [patent_app_type] => utility [patent_app_number] => 11/198040 [patent_app_country] => US [patent_app_date] => 2005-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3674 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0288/20050288300.pdf [firstpage_image] =>[orig_patent_app_number] => 11198040 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/198040
Methods of use fluoroquinolone compounds against maxillary sinus pathogenic bacteria Aug 7, 2005 Abandoned
Array ( [id] => 7250046 [patent_doc_number] => 20050272641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Therapeutic agents for diabetes' [patent_app_type] => utility [patent_app_number] => 11/198511 [patent_app_country] => US [patent_app_date] => 2005-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10165 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272641.pdf [firstpage_image] =>[orig_patent_app_number] => 11198511 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/198511
Therapeutic agents for diabetes Aug 7, 2005 Issued
Array ( [id] => 102498 [patent_doc_number] => 07728038 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-01 [patent_title] => 'Methods for chelation therapy' [patent_app_type] => utility [patent_app_number] => 11/197959 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 24508 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/728/07728038.pdf [firstpage_image] =>[orig_patent_app_number] => 11197959 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/197959
Methods for chelation therapy Aug 3, 2005 Issued
Menu